In contrast, sensorineural hearing loss was reported for 79% of patients with NLRP3 pathogenic variants and 18% with NLRP3 low-penetrance variants (9), indicating that mutations of high-penetrance may be more pathogenic for hearing loss. This evidence concerns the gene NLRP3 and hearing loss disorder.